Researchers from California's Stanford University suggest that a blood test that measures organs' biological age may help prevent and forecast Alzheimer's disease.
Plasma MTBR-tau243 reflects changes in tau pathology and can be used to stage AD tauopathy and to determine if cognitive symptoms are likely due to AD pathology.